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Abstract 
This case report illustrates the use of ExPRESS mini-shunt in a pediatric glaucoma patient. We 
describe the management of steroid-induced glaucoma with ExPRESS mini-shunt in a 9-year-
old boy with allergic keratoconjunctivitis. The intraocular pressure of both of his eyes was 
uncontrolled with medical and laser treatment. Both eyes were treated with ExPRESS mini-
shunt and mitomycin-C. Transient overfiltration with postoperative hypotony occurred in 
both eyes and resolved after 2 weeks. One year postoperatively, intraocular pressure was 
maintained below 21 mm Hg without medication in 1 eye. Bleb needling with mitomycin-C 
was done to maintain filtration. The fellow eye received cataract extraction but developed 
bleb failure a few months afterwards. The intraocular pressure was controlled medically. To 
conclude, ExPRESS mini-shunt is a new surgical option in selected patients. Bleb failure de-
veloped after cataract extraction. Postoperative inflammation should be minimized. Patient 
selection, such as those with stable ocular condition, is important to increase surgical suc-
cess. © 2016 The Author(s) 
 Published by S. Karger AG, Basel 
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Case Report 
A 9-year-old boy was referred by a private ophthalmologist for bilateral steroid-induced 
glaucoma and cataract in May 2012. He had history of allergic keratoconjunctivitis (AKC) 
and was on self-prescribed steroid eye drop 3–4 times a day for 1 year. At presentation, his 
pinhole visual acuity (VA) was 0.3 and 0.2 Snellen decimal in the right eye (RE) and left eye 
(LE), respectively. Intraocular pressure (IOP) with Goldmann applanation tonometer was 41 
mm Hg (RE) and 42 mm Hg (LE) despite topical dorzolamide, timolol, latanoprost, and oral 
acetazolamide. His cup-disc ratio (CDR) was 0.9 in the RE, and relative afferent pupillary 
defect was present. The LE CDR was 0.7. Gonioscopy showed bilateral 360-degree open an-
gles. There was bilateral moderate posterior subcapsular cataract. 
The child was uncooperative for automated visual field testing. Optical coherence to-
mography (OCT) (Spectralis OCT, Heidelberg, Germany) of the retinal nerve fiber layer 
showed severe generalized thinning in the RE and superotemporal and inferotemporal rim 
thinning of the retinal nerve fiber layer in the LE (Fig. 1). IOP remained uncontrolled despite 
maximal topical anti-glaucoma treatment and selective laser trabeculoplasty. AKC symptoms 
were controlled with topical olopatadine. ExPRESS Miniature Glaucoma DeviceP-50 (Alcon, 
Neve-Ilan, Israel) was implanted sequentially in the LE superotemporally 3 weeks later and 
in the RE superonasally 1 month later. The trabeculectomy was conducted according to the 
standard trabeculectomy procedure. The conjunctiva was dissected and a 3 × 3-mm scleral 
flap was created. Subsequently, 0.4 mg/ml mitomycin-C (MMC) was placed subconjunctival-
ly and under the scleral flap for 3 min, followed by irrigation with balanced-salt solution. The 
anterior chamber was then entered under the scleral flap at the grey zone at limbus with a 
25-gauge needle. The ExPRESS device was implanted under the scleral flap through the nee-
dle track. The scleral flap was closed with 2 stitches of 10/0 nylon suture, while the conjunc-
tiva was closed with 8/0 vicryl suture. The patient was started on pred forte 1% eye drop 
every 2 h, and moxifloxacin eye drop 3 times daily postoperatively, taped over 2 months, 
followed by tapering dose of dexoptic-N eye drop (dexamethasone and neomycin) for anoth-
er 3 months. There was overfiltration with hypotony (IOP <6 mm Hg) in the early postopera-
tive period in both eyes, requiring anterior chamber reformation with viscoelastic agent. 
There were no hypotony-related ocular complications including maculopathy and choroidal 
effusion. IOP was controlled in the range of 10–19 mm Hg without the need for any anti-
glaucoma medication since 3 weeks postoperation. The filtering blebs remained functional 
bilaterally, and were small and cystic in RE and diffuse in LE. 
Lens aspiration and implantation of intraocular lens (SA60AT+ 19.0D) (Alcon, 
Fortworth, TX, USA) was performed uneventfully in the RE 4 months after filtration surgery. 
The patient was started on intensive steroid eye drop loteprednol etabonate (lotemax) every 
hourly to reduce inflammation postoperatively. Lotemax was chosen over Pred forte to re-
duce the risk of steroid response. However, IOP in both eyes began to rise above 21 mm Hg, 
and occasionally up to above 40 mm Hg, in the 5 months following the cataract operation, 
despite the use of multiple anti-glaucoma eye drops. In view of failing blebs, subconjunctival 
needling with anti-metabolite injection was performed twice in each eye (RE 50 mg/ml 5-
fluorouracil in first episode and 0.2 mg/ml MMC in second episode; LE 0.2 mg/ml MMC was 
applied for both episodes). The subconjunctival space was entered with a 27-gauge needle, 
the subconjunctival adhesion was lysed and the scleral flap was elevated during the needling 
procedures. However, the anterior chamber was not entered during the presence of the Ex-
PRESS device. IOP remained controlled at 12 mm Hg over the RE and 14 mm Hg over the LE 
at 4 months afterwards although his RE required topical timolol/travoprost for optimal con-
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trol. The LE did not require any anti-glaucoma medications. Fig. 2a, b showed RE underfil-
trating bleb and LE functioning bleb, respectively. In the RE, the best-corrected VA remained 
0.3 Snellen decimal due to advanced glaucoma, while that in the LE was 0.4 Snellen decimal. 
Discussion 
Compared to adults, management of glaucoma in pediatric patients is unique in the sur-
gical difficulties caused by smaller eyes, low scleral rigidity, and thin sclera. Additional chal-
lenges lie in the more intense inflammatory response that can cause a higher failure rate in 
drainage surgery, and difficulties in cooperation for preoperative assessment and postopera-
tive management [1]. 
ExPRESS® Glaucoma Filtration Device is a small metallic shunt that diverts aqueous 
from the anterior chamber to the subtenon space. It was chosen over other filtration surgery 
in this case for several reasons. First, pediatric trabeculectomy is known to have a high rate 
of failure [1]. Anti-fibrotic agents including MMC have been used to increase bleb survival 
but the available evidence is conflicting [2]. There was no significant difference in final IOP 
between groups with conventional trabeculectomy and ExPRESS [3]. However, studies had 
shown significantly higher complete success rate with ExPRESS compared to trabeculectomy 
at 1 year [4, 5]. In our case, IOP was well controlled in the early and intermediate postopera-
tive periods. However, IOP control deteriorated in both eyes soon after RE cataract opera-
tion. We postulate that late IOP rise was triggered by the postoperative inflammatory re-
sponse. 
Reducing postoperative inflammation was another reason why ExPRESS shunt was cho-
sen over trabeculectomy or glaucoma implant. By avoiding iridectomy and reducing the size 
of sclerotomy, ExPRESS implantation causes less postoperative inflammation and subse-
quent scarring at the scleral flap and subconjunctival space, thereby minimizing failure [6]. 
The RE trabeculectomy with ExPRESS implantation failed after cataract extraction probably 
due to inflammation. It might be preferable to perform cataract extraction first and wait 
until the inflammation subsides before proceeding to trabeculectomy. 
ExPRESS shunt also reduces surgical difficulty and surgical trauma for small pediatric 
eyes with shorter operative time. This may explain the quicker recovery of VA at postopera-
tive 1 week in patients with ExPRESS shunt, when compared to 1 month in those with tra-
beculectomy [7]. Faster visual recovery is essential for children undergoing eye operation in 
avoiding amblyopia, as well as helping them resume normal learning activities as soon as 
possible. 
Maris et al. [6] identified a lower hypotony rate of 4% in ExPRESS implantation com-
pared to 32% in trabeculectomy patients. This is a major concern in pediatric filtration sur-
gery as aqueous may drain more easily with low scleral rigidity and thin flap [8]. It was pro-
posed that the standardized lumen of the ExPRESS device gave a fixed controlled resistance 
to the flow of aqueous from anterior chamber to the subtenon space [9], thus reducing over-
filtration. In addition to the concerns about blinding hypotony-related complications, e.g. 
corneal decompensation and maculopathy, if choroidal effusion occurs, the use of cortico-
steroid in a growing child may pose significant systemic side effects. It can also exacerbate 
steroid-induced glaucoma as in our patient. Although hypotony still occurred in our case, its 
severity may be reduced by tighter sutures and smaller scleral flap intraoperatively in future 
cases. Leaving a small amount of viscoelastic agent in the eyes may also help. 
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Potential shortcomings of the ExPRESS device in pediatric glaucoma are that the space 
for insertion of the device is limited by smaller eyes and narrower space in the angle. If the 
device is not inserted in an ideal plane, it may traumatize the corneal endothelium and iris, 
causing pigment dispersion that may worsen IOP control. In addition, as the device is 
planned to be left in the eye for decades in children, there is an increased risk of device ero-
sion, malposition, and dislocation, as active children may be more prone to trauma or simply 
by ocular growth. Therefore, the ExPRESS device may only be suitable in selected group of 
pediatric glaucoma patients, such as those with wide-open angle and older age group in 
which the eyes are relatively more static in size. At the time of writing this case report, we 
only found 1 other case report on the use of the ExPRESS device in a pediatric patient with 
Sturge-Weber syndrome [10]. That patient had a good surgical outcome in terms of IOP con-
trol at 6 months. However, their technique was different from ours, as they inserted the Ex-
PRESS device subconjunctivally (instead of under the scleral flap) and the surgery was per-
formed in 2 stages (ExPRESS device implantation before repeated trabeculectomy) in an eye 
with previous trabeculectomy. 
Another surgical option is glaucoma drainage device (GDD) implantation. Its surgical 
success rate was comparable with trabeculectomy, but it decreased to 42–45% in 4 years’ 
time [11]. Theoretically, a valved GDD has a lower rate of hypotony as the tube only allows 
aqueous to drain at IOP >8 mm Hg. However, hypotony still occurred at a reported rate of 
11–24% [10]. GDD is also associated with its unique tube-related complications, not to men-
tion that it is surgically more demanding than trabeculectomy, making it less than ideal for 
pediatric glaucoma patients. 
In managing pediatric glaucoma patients, we may need special attention in interpreting 
investigations such as OCT. There is no built-in normative database for pediatric subjects, 
and thus the OCT finding should be interpreted with care. The trend of changes may be a 
more important indicator than the absolute value of RNFL thickness. Moreover, specular 
microscopy for endothelial cell count should be monitored in this child after multiple intra-
ocular surgeries. 
Conclusion 
To conclude, ExPRESS device implantation seems to be safe and effective in achieving 
IOP control in at least short to medium term in pediatric glaucoma patients. It can be consid-
ered as an alternative to conventional trabeculectomy. Case selection and avoidance of trig-
gers which may cause shunt failure may enhance success rates in children. Further studies 
would be needed to establish the long-term safety profile and success rate of its use in pedi-
atric patients. 
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Fig. 1. OCT showing severe generalized thinning in the RE (a) and superotemporal and inferotemporal rim 
thinning in the LE (b) of the retinal nerve fiber layer on presentation. 
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Fig. 2. Underfiltrating bleb in the RE (a) and functioning bleb in the LE (b) at around 5 months postfiltra-
tion surgery, with intraocular lens implanted in the RE (the area of the bleb is indicated by arrows, while 
the position of the ExPRESS shunt is indicated by the arrowhead). 
 
